Dr. Philip is a director in the Division of Molecular Genetics and Pathology in the Office of In Vitro Diagnostic Devices and Radiological Health at the Center for Devices and Radiologic Health at the U.S. Food and Drug Administration (FDA). At the FDA, she has been involved in many diverse activities including premarket clearance/approval, manufacturer assistance and post-market regulatory compliance actions. In addition, she has been an ongoing participant in FDA multi-center reviews in companion diagnostics/complementary diagnostics, and is actively working to develop regulatory framework for liquid biopsy tests and NGS-based oncology assays.
Prior to joining the FDA, Dr. Philip’s experience included three years in the U.S. biotechnology industry and postdoctoral training in molecular biology. She received her Ph.D. from the University of Illinois at Urbana-Champaign.
